Pharmaceutical / Drug Definition :
Inhibits thrombus and clot formation by blocking factor Xa and factor IIa. This inhibition accelerates formation of antithrombin III-thrombin complex (a coagulation inhibitor), thereby deactivating thrombin and preventing conversion of fibrinogen to fibrin.
In the United States, Enoxaparin Sodium is regulated by the U.S. Food and Drug Administration (FDA). FDA has specific requirements regarding the registration and listing of Enoxaparin Sodium.
FDA Label Requirements and Exceptions
FDA Import Information
Enoxaparin Sodium (Enoxaparin Sodium Entry Refusal)
General U.S. Food and Drug Administration Guidelines for:
- Manufacturers Enoxaparin Sodium (Enoxaparin Sodium Suppliers)
- Processors Enoxaparin Sodium
- Repackers Enoxaparin Sodium
- Relabelers Enoxaparin Sodium
- Exporters Enoxaparin Sodium
- Importers Enoxaparin Sodium
For more information about Enoxaparin Sodium, simply click below:
U.S. FDA Regulations:
U.S. FDA Regulation: 21 C.F.R. Part 207
Registrar Corp assists businesses with U.S. FDA compliance. Certificates of Registration issued by Registrar Corp provide confirmation to industry that you are fulfilling U.S. FDA registration requirements. U.S. FDA does not issue or recognize Certificates of Registration. Registrar Corp is not affiliated with the U.S. Food and Drug Administration.